Patients referred to a diabetes management and education clinic led by pharmacists saw meaningful improvements in blood sugar levels over time, underscoring the critical role pharmacists can play in supporting this high-risk group

In a recent article published in Nature Cell Biology, University of Chicago researchers identified two small molecules made by gut bacteria, queuine and its chemical precursor pre- queuosine 1 (preQ1), that compete to control our cells’ protein building machinery. The discovery reveals that these two bacterial metabolites act in opposite directions, particularly queuine to promote cell growth, and preQ1 to halt cell growth. The study suggests the growth-suppressing nature of specific microbial metabolites may be useful in developing new cancer therapies. 

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

Researchers gain clues from these giant mammals about cancer resistance. 

Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found that "first-responder" immune cells known as myeloid cells can be manipulated to enhance the activity of tumor-killing T cells.

The QOPI® Certification Program builds on ASCO’s Quality Oncology Practice Initiative, providing a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.  

Scientists at Wake Forest University School of Medicine have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy.